Bio Summary
I am Dr. Youngmi Song, a dedicated researcher with a Ph.D. in Biomedical Science from Yonsei University College of Medicine. Throughout my academic and professional journey, I have contributed significantly to the fields of hepatosteatosis, autophagy, and gut microbiota, among others.
Education
- Ph.D. in Biomedical Science
- Period: September 2011 to February 2015
- Institution: Yonsei University College of Medicine, Seoul, Republic of Korea
Research Focus
My research primarily focuses on understanding and addressing metabolic disorders, with a particular emphasis on hepatosteatosis, nonalcoholic steatohepatitis, and the role of gut microbiota in these conditions. Additionally, I have explored pathways related to autophagy, GLP-1 secretion, and the effects of various pharmacological interventions.
Professional Journey
- Research Professor
- Institution: Medical Research Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
- Period: October 2019 onwards
- Postdoctoral Fellow
- Institution: Luenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Canada
- Period: April 2016 to 2019
- Postdoctoral Fellow
- Institution: Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
- Period: February 2015 to February 2016
Honors & Awards
- Academic Award for Highest Achievement
- Institution: Yonsei University College of Medicine
- Date: February 2015
- Travel Grant
- Event: 9th International Diabetes Federation Western Pacific Region Congress, Kyoto, Japan
- Date: November 2012
Author Metrics
- Citations: 825
- Documents: 11
- h-index: 10
Publications Top Noted & Contributions
I have made substantial contributions to scientific literature, particularly in prestigious journals, shedding light on topics such as gut microbiota, GLP-1 secretion, hepatosteatosis, and autophagy. Noteworthy publications include studies on Gemigliptin, metformin, and the impact of glycated albumin on pancreatic beta-cell function.
Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy
- Journal: Molecular Metabolism (2023)
- Citations: 0
Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion
- Journal: Molecular Metabolism (2020)
- Citations: 37
Gut-Proglucagon-Derived Peptides Are Essential for Regulating Glucose Homeostasis in Mice
- Journal: Cell Metabolism (2019)
- Citations: 78
Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition
- Journal: Autophagy (2017)
- Citations: 146
Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: Animal and human studies
- Journal: Scientific Reports (2016)
- Citations: 76
Metformin restores parkin-mediated mitophagy, suppressed by cytosolic p53
- Journal: International Journal of Molecular Sciences (2016)
- Citations: 67
Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway
- Journal: Autophagy (2015)
- Citations: 229
Research Timeline
- 2011-2015: Pursued Ph.D. in Biomedical Science at Yonsei University College of Medicine.
- 2015-2016: Conducted postdoctoral research on hepatosteatosis and autophagy at Yonsei University College of Medicine.
- 2016-2019: Engaged in postdoctoral research as a Kangbuk Samsung-BBDC International Research Fellow at the University of Toronto.
- 2019-Present: Currently serving as a Research Professor at the Medical Research Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, focusing on metabolic disorders.
